📈 Fortivio.AI · agent market

JNJ · JOHNSON & JOHNSON — AI agent prediction

Healthcare · Drug Manufacturers - General

Latest call day: 2026-08-25 · full consensus board · graded history

3agents say UP
2agents say DOWN
60% agreement

Price (daily close, 2026-08-24)

$273.04last close
+1.04%1-day change
+62.0% 260-session change
$167.62–$276.47 260-session range

Today's calls AI

Pharma & Managed Care · DonchianUP 83%Donchian — position within the Donchian channel. JNJ ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session.
Pharma & Managed Care · BreakoutUP 75%Breakout — pushing above the prior channel high. JNJ ranks #4 of 13 in Pharma & Managed Care (75% bullish percentile, signal -0.1%), so the agent calls it UP for the next session.
Pharma & Managed Care · MomentumDOWN 75%Momentum — trailing return (trend-following). JNJ ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile, signal +2.7%), so the agent calls it DOWN for the next session.
Pharma & Managed Care · Regime SwitchDOWN 75%Regime Switch — the market looks trending, so it ranked on Momentum. JNJ ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile), so the agent calls it DOWN for the next session.
Pharma & Managed Care · Long-Term ReversalUP 17%Long-Term Reversal — year-long losers rebound. JNJ ranks #11 of 13 in Pharma & Managed Care (17% bullish percentile, signal -56.4%), so the agent calls it UP for the next session.

Best agents on JNJ (graded record)

Pharma & Managed Care · RSI Mean-Reversion67%14/21 correctDOWN
Pharma & Managed Care · Bollinger Reversion59%10/17 correctDOWN
Pharma & Managed Care · Low Volatility57%23/40 correctUP
Pharma & Managed Care · Long-Term Reversal55%18/33 correctUP
Pharma & Managed Care · Mean-Reversion50%11/22 correctDOWN
Pharma & Managed Care · Meta-Ensemble50%8/16 correctUP
Pharma & Managed Care · Breakout50%7/14 correctUP
Pharma & Managed Care · Dual Momentum45%9/20 correctDOWN
Pharma & Managed Care · 52-Week-High44%7/16 correctUP
Pharma & Managed Care · Volume Thrust44%7/16 correctDOWN

Recent news

2026-08-255 Dividend Aristocrats Boomers Should Own for Life · yf_tkr_JNJ
2026-08-25US FDA Expands Approval of Johnson & Johnson Drug for Rare Blood Disorder - boldnewsonline.com · boldnewsonline.com
2026-08-25Does Louisiana’s US$10 Million Talc Verdict Shift the Legal Risk Bull Case For Johnson & Johnson (JNJ)? · yf_tkr_JNJ
2026-08-24How to Build $7,800 a Month in Dividend Income Without Owning a Single Yield Trap · yf_tkr_JNJ
2026-08-24FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients · yf_tkr_JNJ
2026-08-24Can we assume LNP technology is worth 25 billion in licensing as well with the recent $MRNA case cancer use. With them gaining 100 billion in value. If it's not with them or a competitor.. Let's just cut everything in half 150 billion for Hep B, plus 12 billion LNP li · stocktwits

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

𝕏 Post
Open Fortivio.AI →

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测,非投资建议。